en
Scientific article
English

Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy

Published inJournal of thrombosis and haemostasis, vol. 11, no. 8, p. 1617-1619
Publication date2013
Keywords
  • ABO Blood-Group System/metabolism
  • Administration, Oral
  • Aged
  • Alleles
  • Case-Control Studies
  • Cytochrome P-450 CYP3A/metabolism
  • Female
  • Gene Frequency
  • Genetic Variation
  • Hormones/administration & dosage
  • Humans
  • Middle Aged
  • NF-E2-Related Factor 2/metabolism
  • Polymorphism, Single Nucleotide
  • Postmenopause
  • Pulmonary Embolism/blood
  • Regression Analysis
  • Risk Factors
  • Venous Thrombosis/blood
  • Washington
Citation (ISO format)
BLONDON, Marc et al. Lack of strong effect modification by NFE2L2/CYP3A5/ABO of the risk of venous thrombosis associated with oral hormone therapy. In: Journal of thrombosis and haemostasis, 2013, vol. 11, n° 8, p. 1617–1619. doi: 10.1111/jth.12309
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1538-7836
363views
0downloads

Technical informations

Creation10/30/2016 1:19:00 PM
First validation10/30/2016 1:19:00 PM
Update time03/15/2023 12:57:06 AM
Status update03/15/2023 12:57:06 AM
Last indexation01/16/2024 10:18:28 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack